SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001694665-23-000182
Filing Date
2023-11-09
Accepted
2023-11-09 17:06:23
Documents
78
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evlo-20230930.htm   iXBRL 10-Q 1385272
2 EX-31.1 exhibit311ceo302certificat.htm EX-31.1 13490
3 EX-31.2 exhibit312cfo302certificat.htm EX-31.2 13515
4 EX-32.1 exhibit321ceo906certificat.htm EX-32.1 8101
5 EX-32.2 exhibit322cfo906certificat.htm EX-32.2 7459
11 evlo-20230930_g1.jpg GRAPHIC 7885
  Complete submission text file 0001694665-23-000182.txt   6292593

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20230930.xsd EX-101.SCH 47152
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evlo-20230930_cal.xml EX-101.CAL 55402
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evlo-20230930_def.xml EX-101.DEF 200183
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20230930_lab.xml EX-101.LAB 603699
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20230930_pre.xml EX-101.PRE 383500
72 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20230930_htm.xml XML 675016
Mailing Address ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38473 | Film No.: 231393645
SIC: 2834 Pharmaceutical Preparations